Investor Hour- learn all you need to know about the program Angel Challenge Health!
A new Swedish cancer ‘atlas’ could glean information, like markers of disease, that can be used to develop cancer drugs and diagnostics.
En fersk rapport fra Menon Economics viser at industrifinansierte, kliniske studier kan gi enorme gevinster for Helse-Norge. – Det er ingen grunn til at antall kliniske studier i Norge skal gå ned. Våre bedrifter rapporterer at de er mer enn klare for studiene, men har problemer med å få avtaler med norske sykehus om klinisk utprøving, sier Kathrine Myhre, leder av Norway Health Tech.
In a cancer research break-through, scientists have found 100 genes in cancer cells that are required in order for cancer immunotherapies to work.
In a breakthrough for regenerative medicine, a tiny device that sits on the skin and uses an electric field to reprogram cells can treat injured or ageing tissue, including in our brains.
Why has a contraceptive pill for men “been 5 years away for 40 years”? These great articles trace the hunt for The Male Pill.
Norges største helseklynge skifter navn. – Vi har passert 200 medlemmer og tar nå en nasjonal posisjon for å løfte norsk helseindustri internasjonalt, sier Kathrine Myhre, leder av Norway Health Tech.